217 related articles for article (PubMed ID: 38794205)
1. Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing.
Liu D; Wu G; Wang S; Zheng X; Che X
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794205
[TBL] [Abstract][Full Text] [Related]
2. Role of NF-κB pathway in kidney renal clear cell carcinoma and its potential therapeutic implications.
Sun J; Chen F; Wu G
Aging (Albany NY); 2023 Oct; 15(20):11313-11330. PubMed ID: 37847185
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
4. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract][Full Text] [Related]
5. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
Sun Y; Xu Y; Che X; Wu G
Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
[TBL] [Abstract][Full Text] [Related]
6. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
8. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
[TBL] [Abstract][Full Text] [Related]
9. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
10. Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma.
Xin S; Sun X; Jin L; Zhou Z; Liu X; Li W; Mei W; Zhang J; Zhang B; Yao X; Zhou L; Ye L
J Oncol; 2022; 2022():9498010. PubMed ID: 35342405
[TBL] [Abstract][Full Text] [Related]
11. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.
Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q
Front Genet; 2022; 13():862210. PubMed ID: 35903358
[No Abstract] [Full Text] [Related]
12. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
16. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
17. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
[TBL] [Abstract][Full Text] [Related]
19. Correlation between IL3 signaling pathway-related genes and immune checkpoint inhibitor efficacy in patients with renal cell carcinoma.
Hou S; Gu T; Shi Y; Huang Y; Yao J; Luo P; Cao M; Zhang J; Lin A; Zhu W
Cancer Biomark; 2023; 38(4):489-504. PubMed ID: 38043008
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics pan-cancer study of cuproptosis core gene
Xu J; Hu Z; Cao H; Zhang H; Luo P; Zhang J; Wang X; Cheng Q; Li J
Front Immunol; 2022; 13():981764. PubMed ID: 36605188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
